Clinical News

PHE Action on Liver Disease & Preview of 2nd Atlas of Variation in Liver Disease

Tuesday, 17 January 2017 14:51

This webinar is for anyone who wants to understand the challenges to reduce liver disease.

By joining the webinar participants will:

  • Explore the variations in liver disease risk factors and outcomes
  • Learn about PHEs programmes of action on liver disease
  • Look at time series data to identify where variation has improved, stayed the same or got worse
  • Explore the stories behind the data
  • Have an opportunity to ask a question to the national team

Registration is FREE for this event and if you have already expressed an interest in attending this webinar, then we will have your details on our system. If you have not registered, please do so at: www.surveys.phe.org.uk/TakeSurvey.aspx?SurveyID=8l218o55.

If you have any questions about registration, please contact This e-mail address is being protected from spambots. You need JavaScript enabled to view it

BSG Comment on publication of 2nd Atlas of Variation in NHS Diagnostic Services in England

Friday, 13 January 2017 09:40

The President of the British Society of Gastroenterology, Professor Martin Lombard commented, saying:

"The British Society of Gastroenterology welcomes the second Atlas of Variation in NHS Diagnostic Services in England; it is clear that unwarranted variation in endoscopy quality and access needs to be addressed. It is vital also that we keep our focus on outcomes rather than levels per se.

"Integral to high quality diagnostic services is the workforce and this cannot be underestimated in the current environment. Not only is this important for endoscopists but also for the wider team, who increasingly play a fundamental role in the delivery of high quality care.

"It is important that endoscopy resources are used in an impactful way and the right types of procedures are better deployed for the patient, such as colonoscopy, capsule endoscopy, flexible sigmoidoscopy and CT colonoscopy whilst procedures such as barium enema, that have no place in modern gastroenterology, are phased out by NHS England."

UK IBD Registry ends year on a high note

Wednesday, 21 December 2016 14:26

We approach the end of the year with 60 sites actively participating in the IBD Registry, and over 21,000 patient records submitted. 80 sites in total have a 'live' system for data capture, and 21 additional sites are in the process of setting up, so we expect patient numbers to increase steadily.

Members of the Registry's industry working group have generously contributed to a fund specifically to support sites with data entry. For more information please contact This e-mail address is being protected from spambots. You need JavaScript enabled to view it by 20th January 2017.

Many thanks to our colleagues at AbbVie, Allergan, Dr Falk, Janssen, Napp, Pfizer, Takeda, Tillotts and Vifor for their contributions to this fund. If you have not yet registered to participate in the IBD Registry, would like help uploading your data, or have any other registry related queries please contact This e-mail address is being protected from spambots. You need JavaScript enabled to view it

*Grants may be higher depending on the number of sites applying.

 

New metrics for the Lancet Standing Commission on Liver Disease in the UK

Friday, 16 December 2016 12:41

The format for this third report of the Lancet Commission follows the same pattern as in 2015 in concentrating on the main recommendations, all of which are evidence based and have been most carefully considered in terms of their ability to reduce the current burden of liver disease in the UK and its financial cost. The working groups set up around the recommendations have concentrated this year on producing a set of the main metrics, which will enable further charting of disease prevalence and consequences on an annual basis.

Page 2 of 12